DE69535561D1 - NUKLEOTID- UND AMINOSÄURESEQUENZEN gB, gC UND gD DES HERPESVIRUS DES HUNDES UND IHRE VERWENDUNGEN - Google Patents
NUKLEOTID- UND AMINOSÄURESEQUENZEN gB, gC UND gD DES HERPESVIRUS DES HUNDES UND IHRE VERWENDUNGENInfo
- Publication number
- DE69535561D1 DE69535561D1 DE69535561T DE69535561T DE69535561D1 DE 69535561 D1 DE69535561 D1 DE 69535561D1 DE 69535561 T DE69535561 T DE 69535561T DE 69535561 T DE69535561 T DE 69535561T DE 69535561 D1 DE69535561 D1 DE 69535561D1
- Authority
- DE
- Germany
- Prior art keywords
- disclosed
- chv
- nucleotides
- useful
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002773 nucleotide Substances 0.000 title abstract 5
- 150000001413 amino acids Chemical group 0.000 title abstract 2
- 241001529453 unidentified herpesvirus Species 0.000 title 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 241000680578 Canid alphaherpesvirus 1 Species 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 230000001900 immune effect Effects 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000700663 Avipoxvirus Species 0.000 abstract 1
- 239000003298 DNA probe Substances 0.000 abstract 1
- 241000700618 Vaccinia virus Species 0.000 abstract 1
- 206010046865 Vaccinia virus infection Diseases 0.000 abstract 1
- 208000007089 vaccinia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/220,151 US5529780A (en) | 1994-03-30 | 1994-03-30 | Nucleotide and amino acid sequences of canine herpesvirus gB and gC |
| US220151 | 1994-03-30 | ||
| US413118 | 1995-03-29 | ||
| US08/413,118 US5688920A (en) | 1994-03-30 | 1995-03-29 | Nucleotide and amino acid sequences for canine herpesvirus GB, GC and GD and uses therefor |
| PCT/US1995/003982 WO1995026751A1 (en) | 1994-03-30 | 1995-03-30 | NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69535561D1 true DE69535561D1 (de) | 2007-09-27 |
| DE69535561T2 DE69535561T2 (de) | 2008-06-05 |
Family
ID=26914613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69535561T Expired - Lifetime DE69535561T2 (de) | 1994-03-30 | 1995-03-30 | NUKLEOTID- UND AMINOSÄURESEQUENZEN gB, gC UND gD DES HERPESVIRUS DES HUNDES UND IHRE VERWENDUNGEN |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6017542A (de) |
| EP (1) | EP0752888B1 (de) |
| JP (1) | JP3745370B2 (de) |
| AT (1) | ATE369876T1 (de) |
| AU (1) | AU683557B2 (de) |
| CA (1) | CA2182888C (de) |
| DE (1) | DE69535561T2 (de) |
| DK (1) | DK0752888T3 (de) |
| ES (1) | ES2293639T3 (de) |
| WO (1) | WO1995026751A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
| US5753235A (en) * | 1996-02-15 | 1998-05-19 | Heska Corporation | Recombinant canine herpesviruses |
| FR2750865B1 (fr) * | 1996-06-27 | 1998-12-04 | Rhone Merieux | Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2 |
| KR100768114B1 (ko) * | 1999-06-10 | 2007-10-17 | 메리알 | 애완 동물 및 스포츠용 동물을 위한 ｄｎａ 백신 |
| US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| BRPI0610503B1 (pt) * | 2005-04-21 | 2022-05-31 | University Of Florida Research Foundation | Composições compreendendo vírus influenza, polinucleotídeo isolado, polipeptídeo ou vírus reagrupado, bem como construção de expressão de polinucleotídeo, oligonucleotídeo, micro-organismo transgênico, e métodos para a detecção de um vírus influenza que é capaz de infectar um animal canídeo |
| PL2611460T3 (pl) * | 2010-08-31 | 2017-02-28 | Merial, Inc. | Szczepionki przeciw herpeswirusom przenoszone z pomocą wirusa choroby newcastle |
| CN109212205B (zh) * | 2017-06-29 | 2021-08-20 | 洛阳普泰生物技术有限公司 | 伪狂犬病病毒gC蛋白抗体、含该抗体的试剂盒及应用 |
| US11857622B2 (en) | 2020-06-21 | 2024-01-02 | Pfizer Inc. | Human cytomegalovirus GB polypeptide |
| CN116497049B (zh) * | 2023-05-04 | 2024-03-22 | 江苏三仪生物工程有限公司 | 一种表达犬疱疹病毒gD糖基化蛋白的重组菌及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338683A (en) * | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
| FR2659349B1 (fr) * | 1990-03-12 | 1993-12-24 | Rhone Merieux | Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus. |
-
1995
- 1995-03-30 EP EP95915474A patent/EP0752888B1/de not_active Expired - Lifetime
- 1995-03-30 WO PCT/US1995/003982 patent/WO1995026751A1/en active IP Right Grant
- 1995-03-30 AU AU22344/95A patent/AU683557B2/en not_active Expired
- 1995-03-30 DE DE69535561T patent/DE69535561T2/de not_active Expired - Lifetime
- 1995-03-30 ES ES95915474T patent/ES2293639T3/es not_active Expired - Lifetime
- 1995-03-30 JP JP52584995A patent/JP3745370B2/ja not_active Expired - Lifetime
- 1995-03-30 CA CA002182888A patent/CA2182888C/en not_active Expired - Lifetime
- 1995-03-30 AT AT95915474T patent/ATE369876T1/de active
- 1995-03-30 DK DK95915474T patent/DK0752888T3/da active
- 1995-06-07 US US08/473,446 patent/US6017542A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2182888A1 (en) | 1995-10-12 |
| CA2182888C (en) | 2007-08-07 |
| EP0752888A4 (de) | 1997-05-21 |
| ATE369876T1 (de) | 2007-09-15 |
| DE69535561T2 (de) | 2008-06-05 |
| AU2234495A (en) | 1995-10-23 |
| AU683557B2 (en) | 1997-11-13 |
| WO1995026751A1 (en) | 1995-10-12 |
| JP3745370B2 (ja) | 2006-02-15 |
| EP0752888B1 (de) | 2007-08-15 |
| ES2293639T3 (es) | 2008-03-16 |
| EP0752888A1 (de) | 1997-01-15 |
| DK0752888T3 (da) | 2007-12-03 |
| US6017542A (en) | 2000-01-25 |
| JPH09511145A (ja) | 1997-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU613291B2 (en) | Fowlpox virus promoters | |
| AU691374B2 (en) | 5' to 3' exonuclease mutations of thermostable DNA polymerases | |
| WO2000075350A3 (en) | Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use | |
| WO1998050554A3 (en) | Enterococcus faecalis polynucleotides and polypeptides | |
| WO1999029871A3 (fr) | Sequences de circovirus associe a la maladie de l'amaigrissement du porcelet (map) | |
| WO2000003685A3 (en) | Nitrilase homologs | |
| DE69535561D1 (de) | NUKLEOTID- UND AMINOSÄURESEQUENZEN gB, gC UND gD DES HERPESVIRUS DES HUNDES UND IHRE VERWENDUNGEN | |
| EP1005540A4 (de) | Ikk-beta proteines, nukleinsäuren und verfahren | |
| EP1717315A3 (de) | Osteoprotegerin bindende Proteine und Rezeptoren | |
| KR900700508A (ko) | 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질 | |
| CA2289872A1 (en) | Target-dependent reactions using structure-bridging oligonucleotides | |
| DE69433690D1 (de) | Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür | |
| EP1810978A3 (de) | Für Polypeptide aus Gruppe-B-Streptokokkus kodierende Nukleinsäuren und therapeutische Zusammensetzung sowie Impfstoffe daraus | |
| WO1996015144A3 (en) | Chromosome 21 gene marker, compositions and methods using same | |
| Dupuis et al. | NADH: ubiquinone oxidoreductase from bovine mitochondria. cDNA sequence of a 19 kDa cysteine-rich subunit | |
| WO1995006735A3 (en) | Nucleotide sequences for novel protein tyrosine phosphatases | |
| ZA959416B (en) | Carrier protein having an adjuvant effect immunogenic complex containing it process for their preparation nuclofotide sequence and vaccine | |
| EP1613345A4 (de) | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 | |
| WO1994013812A3 (en) | Novel entomopoxvirus genes, proteins and methods of use thereof | |
| DE69838644D1 (de) | Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors | |
| CA2066160A1 (en) | Marek's disease herpesvirus dna segment encoding glycoproteins, gd, gi and ge | |
| WO2002074960A3 (en) | 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof | |
| ENDOH et al. | Expression and purification of recombinant Marek's disease virus serotype 1 specific phosphorylated protein pp38 in E. coli | |
| NO178504C (no) | Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat | |
| WO1999004825A8 (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: CONNAUGHT TECHNOLOGY CORP., GREENVILLE, DEL., US |
|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN |
|
| 8364 | No opposition during term of opposition |